• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

队列研究非酒精性脂肪性肝病、NAFLD 纤维化评分与韩国人群中糖尿病发病风险的关系。

Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population.

机构信息

1] Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine, Seoul, South Korea [2] Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine, Seoul, South Korea.

出版信息

Am J Gastroenterol. 2013 Dec;108(12):1861-8. doi: 10.1038/ajg.2013.349. Epub 2013 Oct 8.

DOI:10.1038/ajg.2013.349
PMID:24100261
Abstract

OBJECTIVES

No study has evaluated an association between non-alcoholic fatty liver disease (NAFLD) severity and the incidence of diabetes. We examined whether NAFLD and its severity-using the NAFLD fibrosis score (NFS)-predict the development of diabetes.

METHODS

A cross-sectional study was performed in 43,166 apparently healthy Koreans aged 30-59 years, who underwent a health checkup in 2005 and 2006. Of these, 38,291 subjects without diabetes were followed annually or biennially until December 2011 for the cohort study. NAFLD was defined as hepatic steatosis on ultrasonography in the absence of excessive alcohol use or other identifiable causes. The NFS was used to categorize the severity of fibrosis. Diabetes was defined as fasting serum glucose ≥126 mg/dl, glycated hemoglobin (HbA1c) ≥6.5%, or medication use for diabetes.

RESULTS

During 175,996 person-years of follow-up, 2,025 participants developed diabetes. An increase across NAFLD categories was positively associated with an increased risk of diabetes in both the cross-sectional and cohort studies in a dose-response manner (P-trend <0.001). In multivariate-adjusted models, the hazard ratios (95% confidence intervals) for diabetes comparing NAFLD with low NFS and NAFLD with intermediate or high NFS vs. no NAFLD were 2.00 (1.79-2.24) and 4.74 (3.67-6.13), respectively. This association remained significant even in subjects with fasting glucose <100 mg/dl and subjects with HbA1c <5.8%.

CONCLUSIONS

In this cohort study of a healthy Korean population, NAFLD and its severity using NFS were independently and strongly associated with increased incidence of diabetes in men and women-even with a euglycemic range of glucose and HbA1c.

摘要

目的

目前尚无研究评估非酒精性脂肪性肝病(NAFLD)严重程度与糖尿病发病之间的关系。本研究旨在探讨 NAFLD 及其严重程度(采用 NAFLD 纤维化评分[NFS])是否可预测糖尿病的发生。

方法

本研究为横断面研究,纳入了 2005 年至 2006 年期间于韩国接受健康体检的 43166 名 30-59 岁的貌似健康人群。其中,38291 名无糖尿病的受试者在随访期间每年或每 2 年接受一次随访,直至 2011 年 12 月进行队列研究。NAFLD 通过超声检查在无过量饮酒或其他可识别病因的情况下定义为肝脂肪变性。采用 NFS 对纤维化严重程度进行分类。糖尿病的定义为空腹血糖≥126mg/dl、糖化血红蛋白(HbA1c)≥6.5%或使用降糖药物。

结果

在 175996 人年的随访期间,2025 名受试者发生了糖尿病。在横断面和队列研究中,NAFLD 各分类与糖尿病风险呈正相关,且呈剂量-反应关系(趋势 P<0.001)。在校正多变量模型后,与无 NAFLD 相比,NAFLD 伴低 NFS 和 NAFLD 伴中/高 NFS 患者发生糖尿病的风险比(95%置信区间)分别为 2.00(1.79-2.24)和 4.74(3.67-6.13)。即使在空腹血糖<100mg/dl 和 HbA1c<5.8%的受试者中,这种相关性仍然显著。

结论

在这项针对韩国健康人群的队列研究中,NAFLD 及其严重程度(采用 NFS)与男性和女性糖尿病的发生率增加独立且密切相关,即使在血糖和 HbA1c 处于正常范围时也是如此。

相似文献

1
Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population.队列研究非酒精性脂肪性肝病、NAFLD 纤维化评分与韩国人群中糖尿病发病风险的关系。
Am J Gastroenterol. 2013 Dec;108(12):1861-8. doi: 10.1038/ajg.2013.349. Epub 2013 Oct 8.
2
Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes.糖化血红蛋白与无糖尿病的非酒精性脂肪性肝病患者发生晚期纤维化的风险相关。
Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):58-66. doi: 10.1016/j.clinre.2018.08.007. Epub 2018 Sep 28.
3
Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者肝纤维化与冠心病风险之间的关联
Eur J Gastroenterol Hepatol. 2015 Mar;27(3):298-304. doi: 10.1097/MEG.0000000000000286.
4
Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study.吸烟与非酒精性脂肪性肝病风险:队列研究。
Am J Gastroenterol. 2019 Mar;114(3):453-463. doi: 10.1038/s41395-018-0283-5.
5
Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus.非酒精性脂肪性肝病对糖尿病发病的影响。
J Gastroenterol Hepatol. 2013 Jan;28(1):142-7. doi: 10.1111/j.1440-1746.2012.07264.x.
6
The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study.瘦素与非酒精性脂肪性肝病严重程度的相关性:一项基于人群的研究。
Clin Mol Hepatol. 2018 Dec;24(4):392-401. doi: 10.3350/cmh.2018.0011. Epub 2018 Aug 2.
7
Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.非肥胖绝经后女性血清尿酸水平与肝脂肪变性的关系。
Climacteric. 2014 Dec;17(6):692-9. doi: 10.3109/13697137.2014.926323. Epub 2014 Aug 7.
8
Nonalcoholic Fatty Liver Disease Is Associated with Increased Risk of Reflux Esophagitis.非酒精性脂肪性肝病与反流性食管炎风险增加相关。
Dig Dis Sci. 2017 Dec;62(12):3605-3613. doi: 10.1007/s10620-017-4805-6. Epub 2017 Oct 23.
9
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.美国非酒精性脂肪性肝病成人患者中无创性纤维化标志物与死亡率之间的关系。
Hepatology. 2013 Apr;57(4):1357-65. doi: 10.1002/hep.26156. Epub 2013 Jan 25.
10
Non-alcoholic fatty liver disease and the development of nephrolithiasis: A cohort study.非酒精性脂肪性肝病与肾结石的发生:一项队列研究。
PLoS One. 2017 Oct 26;12(10):e0184506. doi: 10.1371/journal.pone.0184506. eCollection 2017.

引用本文的文献

1
Integrated Patient Digital and Biomimetic Twins for Precision Medicine: A Perspective.用于精准医学的综合患者数字双胞胎和仿生双胞胎:一种观点
Semin Liver Dis. 2025 Jul 23. doi: 10.1055/a-2649-1560.
2
Exploring the Prevalence and Risk Factors of MASLD in Patients with Newly Diagnosed Diabetes Mellitus: A Comprehensive Investigation.探索新诊断糖尿病患者中代谢相关脂肪性肝病的患病率及危险因素:一项全面调查
J Clin Med. 2025 May 17;14(10):3513. doi: 10.3390/jcm14103513.
3
Prevalence of Pancreatic Steatosis and Its Associated Factors in Turkey: A Nation-Wide Multicenter Study.
土耳其胰腺脂肪变性的流行情况及其相关因素:一项全国多中心研究。
Turk J Gastroenterol. 2024 Mar;35(3):239-254. doi: 10.5152/tjg.2024.23583.
4
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.非酒精性脂肪性肝病或代谢相关脂肪性肝病患者 2 型糖尿病的全球流行病学:系统评价和荟萃分析。
BMC Med. 2024 Mar 6;22(1):101. doi: 10.1186/s12916-024-03315-0.
5
Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA study.非酒精性脂肪性肝病与 2 型糖尿病发病风险的种族差异:来自 CARDIA 研究的结果。
Diabetologia. 2023 Jul;66(7):1235-1246. doi: 10.1007/s00125-023-05903-w. Epub 2023 Mar 21.
6
infection increases the risk of nonalcoholic fatty liver disease in diabetic population.感染会增加糖尿病患者患非酒精性脂肪性肝病的风险。
Front Nutr. 2023 Feb 1;10:1076579. doi: 10.3389/fnut.2023.1076579. eCollection 2023.
7
MAFLD: a multisystem disease.代谢相关脂肪性肝病:一种多系统疾病。
Ther Adv Endocrinol Metab. 2023 Jan 28;14:20420188221145549. doi: 10.1177/20420188221145549. eCollection 2023.
8
Gut microbiota: The key to the treatment of metabolic syndrome in traditional Chinese medicine - a case study of diabetes and nonalcoholic fatty liver disease.肠道微生物群:中医治疗代谢综合征的关键——以糖尿病和非酒精性脂肪性肝病为例
Front Immunol. 2022 Dec 23;13:1072376. doi: 10.3389/fimmu.2022.1072376. eCollection 2022.
9
Non-alcoholic fatty liver disease: Definition and subtypes.非酒精性脂肪性肝病:定义和亚型。
Clin Mol Hepatol. 2023 Feb;29(suppl):S5-S16. doi: 10.3350/cmh.2022.0424. Epub 2022 Dec 28.
10
Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH).非酒精性脂肪性肝病临床管理与照护的当前考量:来自加拿大非酒精性脂肪性肝炎网络(CanNASH)第一届国际研讨会的见解
Can Liver J. 2022 Feb 4;5(1):61-90. doi: 10.3138/canlivj-2021-0030. eCollection 2022 Winter.